The civil society monitoring of hepatitis C response related to the WHO 2030 elimination goals in 35 European countries

• Päätekijät: M. Maticic (Tekijä), Z. Pirnat (Tekijä), A. Leicht (Tekijä), R. Zimmermann (Tekijä), T. Windelinck (Tekijä), M. Jauffret-Roustide (Tekijä), E. Duffell (Tekijä), T. Tammi (Tekijä), E. Schatz (Tekijä)
• Aineistotyyppi: Kirja
• Julkaistu: BMC, 2020-11-01T00:00:00Z.
• Aiheet: article
• Linkit: Connect to this object online.

Abstract Background People who inject drugs (PWID) account for the majority of new cases of hepatitis C virus (HCV) infection in Europe; however, HCV testing, and treatment for PWID remain suboptimal. With the advent of direct acting antivirals (DAAs) the World Health Organization (WHO) adopted a st...